Home
  >  
Section 67
  >  
Chapter 66,557

Discovery of novel 2,3-dihydro-1H-inden-1-amine derivatives as selective monoamine oxidase B inhibitors

Li, S.; Lv, X.; Cheng, K.; Tian, Y.; Huang, X.; Kong, H.; Duan, Y.; Han, J.; Liao, C.; Xie, Z.

Bioorganic and Medicinal Chemistry Letters 29(9): 1090-1093

2019

ISSN/ISBN: 0960-894X
PMID: 30833108
DOI: 10.1016/j.bmcl.2019.02.030
Accession: 066556370
Download citation:  
Text
  |  
BibTeX
  |  
RIS
Inhibition of MAO-B has been an effective strategy for the treatment of Parkinson's disease. To find more potent and selective MAO-B inhibitors with novel chemical scaffold, we designed and synthesized a series of new 2,3-dihydro-1H-inden-1-amine derivatives on basis of our previous study. Furthermore, the corresponding structure-activity relationship (SAR) of these compounds is detailedly discussed. Compounds L4 (IC50 = 0.11 μM), L8 (IC50 = 0.18 μM), L16 (IC50 = 0.27 μM) and L17 (IC50 = 0.48 μM) showed similar MAO-B inhibitory activity as Selegiline. Moreover, L4, L16 and L17 also exhibited comparable selectivity with Selegiline, indicating that L4, L16 and L17 could be promising selective MAO-B inhibitors for further study.

PDF emailed within 0-6 h: $19.90




Related References

Xiao, X.; Zhang, X.-X.; Zhan, M.-M.; Cheng, K.; Li, S.; Xie, Z.; Liao, C. 2018: Design, synthesis and bioevalucation of novel 2,3-dihydro-1H-inden-1-amine derivatives as potent and selective human monoamine oxidase B inhibitors based on rasagiline European Journal of Medicinal Chemistry 145: 588-593
Morikawa, F.; Ueda, T.; Arai, Y.; Kinemuchi, H. 1986: Inhibition of monoamine oxidase A-form and semicarbazide-sensitive amine oxidase by selective and reversible monoamine oxidase-A inhibitors, amiflamine and FLA 788(+) Pharmacology 32(1): 38-45
Morikawa, F.; Ueda, T.; Arai, Y.; Kinemuchi, H. 1986: Inhibition of monoamine oxidase A-form and semicarbazide sensitive amine-oxidase by selective and reversible monoamine oxidase-A inhibitors, amiflamine and FLA 788(+) Pharmacology 32(1): 33-45
Chimenti, F.; Bolasco, A.; Manna, F.; Secci, D.; Chimenti, P.; Granese, A.; Befani, O.; Turini, P.; Alcaro, S.; Ortuso, F. 2006: Synthesis and molecular modelling of novel substituted-4,5-dihydro-(1H)-pyrazole derivatives as potent and highly selective monoamine oxidase-A inhibitors Chemical Biology and Drug Design 67(3): 206-214
Chimenti, F.; Bolasco, A.; Manna, F.; Secci, D.; Chimenti, P.; Granese, A.; Befani, O.; Turini, P.; Cirilli, R.; La Torre, F.; Alcaro, S.; Ortuso, F.; Langer, T. 2006: Synthesis, biological evaluation and 3D-QSAR of 1,3,5-trisubstituted-4,5-dihydro-(1H)-pyrazole derivatives as potent and highly selective monoamine oxidase a inhibitors Current Medicinal Chemistry 13(12): 1411-1428
Kong, H.; Meng, X.; Hou, R.; Yang, X.; Han, J.; Xie, Z.; Duan, Y.; Liao, C. 2021: Novel 1-(prop-2-yn-1-ylamino)-2,3-dihydro-1H-indene-4-thiol derivatives as potent selective human monoamine oxidase B inhibitors: Design, SAR development, and biological evaluation Bioorganic and Medicinal Chemistry Letters 43: 128051
Foot, J.S.; Deodhar, M.; Turner, C.I.; Yin, P.; van Dam, E.M.; Silva, D.G.; Olivieri, A.; Holt, A.; McDonald, I.A. 2012: The discovery and development of selective 3-fluoro-4-aryloxyallylamine inhibitors of the amine oxidase activity of semicarbazide-sensitive amine oxidase/vascular adhesion protein-1 (SSAO/VAP-1) Bioorganic and Medicinal Chemistry Letters 22(12): 3935-3940
Ziegelhoeffer A.; De Jong J.W.; Ferrari R.; Turi Nagy L. 1988: Methylamine excretion in rats treated with selective inhibitors of monoamine oxidase (MAO) or semicarbazide-sensitive amine oxidase (SSAO) Pharmacological Research Communications 20(Supp-S4): 177-178
Pisani, L.; Muncipinto, G.; Miscioscia, T.Fabiola.; Nicolotti, O.; Leonetti, F.; Catto, M.; Caccia, C.; Salvati, P.; Soto-Otero, R.; Mendez-Alvarez, E.; Passeleu, C.; Carotti, A. 2009: Discovery of a novel class of potent coumarin monoamine oxidase B inhibitors: development and biopharmacological profiling of 7-[(3-chlorobenzyl)oxy]-4-[(methylamino)methyl]-2H-chromen-2-one methanesulfonate (NW-1772) as a highly potent, selective, reversible, and orally active monoamine oxidase B inhibitor Journal of Medicinal Chemistry 52(21): 6685-6706
Kinemuchi, H.; Morikawa, F.; Ueda, T.; Arai, Y. 1986: Studies of monoamine oxidase and semicarbazide-sensitive amine oxidase. I. Inhibition by s selective monoamine oxidase-B inhibitor, Md 780236 The Japanese Journal of Pharmacology 41(2): 183-189
Kinemuchi, H.; Morikawa, F.; Ueda, T.; Arai, Y. 1986: Studies of monoamine oxidase and semicarbazide-sensitive amine oxidase. I. Inhibition by a selective monoamine oxidase-B inhibitor, MD 780236 Japanese Journal of Pharmacology 41(2): 183-189
Kinemuchi, H.; Morikawa, F.; Ueda, T. 1984: Mechanisms of inhibition of semicarbazide sensitive amine oxidase by selective monoamine oxidase inhibitors amiflamine fla 788 dextro 4 monomethylamino alpha 2 dimethylphenethylamine and md 780236 racemic almoxatone mesylate Japanese Journal of Pharmacology 36(Suppl): 302P
Zeller, V.; Ramachander, G.; Zeller, E.A. 1965: Amine Oxidases. Xxi. A Rapid Method for the Determination of the Activity of Monoamine Oxidase and Monoamine Oxidase Inhibitors 1 Journal of Medicinal Chemistry 8(4): 440-443
Zeller, V.; Ramachander, G.; Zeller, E.A. 1965: Amine oxidases. XXI. A rapid method for the determination of the activity of monoamine oxidase and monoamine oxidase inhibitors Journal of Medicinal Chemistry 8(4): 440-443
Chimenti, F.; Bolasco, A.; Manna, F.; Secci, D.; Chimenti, P.; Befani, O.; Turini, P.; Giovannini, V.; Mondovì, B.; Cirilli, R.; La Torre, F. 2004: Synthesis and selective inhibitory activity of 1-acetyl-3,5-diphenyl-4,5-dihydro-(1H)-pyrazole derivatives against monoamine oxidase Journal of Medicinal Chemistry 47(8): 2071-2074
Guglielmi, P.; Carradori, S.; Ammazzalorso, A.; Secci, D. 2019: Novel approaches to the discovery of selective human monoamine oxidase-B inhibitors: is there room for improvement? Expert Opinion on Drug Discovery 14(10): 995-1035
Florvall, L.; Fagervall, I.; Ask, A.L.; Ross, S.B. 1986: Selective monoamine oxidase inhibitors. 4. 4-Aminophenethylamine derivatives with neuron-selective action Journal of Medicinal Chemistry 29(11): 2250-2256
Yao, W.; Wasserman, Z.R.; Chao, M.; Reddy, G.; Shi, E.; Liu, R.Q.; Covington, M.B.; Arner, E.C.; Pratta, M.A.; Tortorella, M.; Magolda, R.L.; Newton, R.; Qian, M.; Ribadeneira, M.D.; Christ, D.; Wexler, R.R.; Decicco, C.P. 2001: Design and synthesis of a series of (2R)-N(4)-hydroxy-2-(3-hydroxybenzyl)-N(1)- [(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]butanediamide derivatives as potent, selective, and orally bioavailable aggrecanase inhibitors Journal of Medicinal Chemistry 44(21): 3347-3350
Severina, I.S.; Kozlova, I.S. 1973: Amine binding with mitochondrial monoamine oxidase and the selective inhibition of enzymatic activity by pyridine derivatives Biokhimiia 38(5): 1076-1082
Wang, D.; Hong, R-Yuan.; Guo, M.; Liu, Y.; Chen, N.; Li, X.; Kong, D-Xin. 2019: Novel C7-Substituted Coumarins as Selective Monoamine Oxidase Inhibitors: Discovery, Synthesis and Theoretical Simulation Molecules 24(21)